| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2965658 | Journal of Cardiovascular Disease Research | 2010 | 5 Pages |
Abstract
Atherosclerosis is the leading cause of death in developed countries. High density lipoproteins (HDL) cholesterol level correlates inversely with the risk of cardiovascular diseases. Thus, HDL has obtained lots of interest for drug development. In this review, we summarized the mechanisms for the antiatherogenic function of HDL, current HDL-based drugs in clinical use and the future direction for HDL-based therapy development.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Xuan Gao, Shujun Yuan,